CheckMan Stock Market Overview
Trending Stocks
Red List
In Today's Headlines

SKHY rides surging AI data-center demand, expands HBM capacity and U.S. production, and deepens its NVIDIA partnership as memory shortages persist.

NVT's power utility growth is benefiting from rising electricity demand, AI data centers and grid modernization, adding another growth avenue.

Shore Capital has reiterated its sell recommendation on HSBC Holdings PLC (LSE:HSBA, NYSE:HSBC), warning the shares' punchy valuation more than reflects the bank's confident outlook. Analyst Gary Greenwood kept his 1,335p target price, implying 13% downside from the current level.

Credo Technology delivered record Q1 results, with revenues up 115% year-over-year on strong demand for its AI data center connectivity products. Despite beating top- and bottom-line estimates, CRDO shares dropped 20%, mainly due to concerns about a 2.9 PP GAAP gross margin contraction, driven by product mix changes. I see the market's reaction as excessive, given CRDO's strategic transition to higher-value integrated modules and the robust, long-term AI infrastructure CapEx cycle.

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that its Chief Financial Officer Mark Livingston will present at the Wells Fargo 21st Annual Healthcare Conference in Boston, MA on Tuesday, September 8, 2026, at 11:00 a.m. ET.

F recalls nearly 149K Mustang vehicles over an electrical wiring defect that could cause loss of drive power or disrupt key functions.

NetApp posts record fiscal Q1 results as AI and modernization demand fuels revenue growth, flash momentum and a raised fiscal 2027 outlook.

Initial XcellaraHeart™ orders ship next week, marking the commercial launch of the Xcellara™ cellular wellness platform; Company prepares XcellaraResilience™ for October launch and highlights the retirement of major convertible debt and 43.25M insider shares. LAS VEGAS, NV / ACCESS Newswire / September 3, 2026 / BioAdaptives, Inc. (OTCID:BDPT), a developer of science-driven human renewal formulations, today announced that the first commercial orders for XcellaraHeart™ will ship next week.

The data center story is constantly making headlines. What started about demand — still a key factor — has become about financing, with environmental implications.

The Dutch central bank has yanked more than 78 metric tons of gold out of New York, citing the tumultuous international climate.
